|
|
Programs and Services
|
|
|
|
Resources
|
|
|
|
Community Events
|
|
|
|
|
|
|
|
|
|
Share-Ap
|
|
|
|
|
|
SHARE-AP
|
1721 Chiefswood Road
|
P.O. Box 5000
|
|
Ohsweken, ON
|
N0A 1M0
|
519-445-2226
|
519-445-0801
|
|
|
|
|
|
|
|
|
Other Programs Offered:
- SHARE-AP EPI:
a continuation of SHARE-AP study. Completed 185 clinic visits.
- ACCORD:
Action to control Cardiovascular risks in Diabetes. A research study for people with Type 2 Diabetes offering blood glucose control, and/either blood pressure control or cholesterol control. No cost for testing supplies or medications. Three participants here, over 10,000 in total in United States and Canada. Ramdomization was completed.
- DREAM:
Diabetes Reduction Assessment with Medications. DREAM is an international clinical trial that is testing the possibility that either the medication Ramipril and/or Rosiglitazone may reduce the risk of developing Type 2 Diabetes. DREAM is also looking at factors that may contribute to the development of diabetes so that in the future we can further understand the causes of diabetes. 41 participants.
- EPI-DREAM:
A sub study of DREAM. Participants screened and involved 236. Completed telephone follow-up. 1 year questionnaires.
- SHARE-AP FOLLOW UP:
PHASE II of SHARE-AP, participants completing clinic visit after 5 years. On hold presently.
|
|
Present staff at Six Nations site:
A. Darlene Davis, Study Coordinator
Completed clinical work, physical health assessments and ECG
Karen L.L. Hill, Recruitment/Secretary
Completed recruitment, participant databases, computer randomized lists, secretarial duties
Viola McCarthy, Laboratory Technician
Completed laboratory components for SHARE-AP EPI, ACCORD and DREAM
Dr. Sonia Anand, Principal Investigator
SHARE-AP, EPI, DREAM, SHARE-AP FOLLOW-UP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|